Use of the drug verapamil to treat Type 1 diabetes continues to show benefits lasting at least two years, researchers report. Patients taking the oral blood pressure medication not only required less daily insulin two years after first diagnosis of the disease, but also showed evidence of surprising immunomodulatory benefits.